Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes

Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes

Introduction The study aimed to assess the effect of COVID-19 on hepatic lipid (HL) content, fibrosis risk, and adiposity in persons with type 2 diabetes.Research design and methods Participants with type 2 diabetes with a history of mild COVID-19 (n=15, age 58±12 years, body mass index 30.9±5.2 kg/...

Full description

Bibliographic Details
Main Authors: Michael Roden, A Icks, Robert Wagner, R Wagner, G Geerling, Volker Burkart, H Al-Hasani, C Herder, J Kotzka, O Kuß, E Lammert, W Rathmann, J Szendroedi, S Schlesinger, M Roden, Katsiaryna Prystupa, Vera Schrauwen-Hinderling, K Jandeleit-Dahm, S Trenkamp, V Schrauwen-Hinderling, Sandra Trenkamp, Yuliya Kupriyanova, Iryna Yurchenko, Pavel Bobrov, Frederik Bartels, Stefan Wierichs, Marc Jonuscheit, Benedict Korzekwa, Martin Schön, Dania Mendez, B Belgardt, G Bönhof
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/13/1/e004727.full

Internet

https://drc.bmj.com/content/13/1/e004727.full

Similar Items